Product Description
Capitalise on the ultimate protection with Havrix 720 Junior Monodose Vaccine, expertly designed for children aged 1-15 years. This customizable vaccine presents as a slightly opaque, colorless to pale yellow suspension containing the ineffable inactivated Hepatitis A virus antigen (HM175 strain). Suitable for soaring health standards, it is delivered in a monodose pre-filled syringe for single-dose administration followed by a booster at 6-12 months. Promotion of safety is prioritized: it boasts WHO prequalification, DCGI approval, and comes with a 36-month shelf life. Store between 2C to 8C, away from light.
Effortless Administration and Superior Advantages
Havrix 720 Junior Monodose Vaccine is administered intramuscularly, with dosage guidelines of a single 0.5 ml dose followed by a booster at 6-12 months. Usage is streamlined by the pre-filled syringe, offering both consistency and ease. Competitive advantages include its robust inactivated vaccine technology and WHO/DCGI approvals. Tailored for children, its single-use format minimises waste and ensures proper immunization. Capitalise on superior efficacy and protection against hepatitis A for your child.
Certifications, Packing & Dispatch, and Export Delivery
Havrix 720 Junior Monodose Vaccine holds WHO prequalification and DCGI approval, attesting to its global and national quality. Packing & Dispatch are conducted meticulously, with one pre-filled syringe securely packed per carton, and the batch number clearly marked. Swift handover and delivery are guaranteed to premier export markets, particularly India and other regulated regions. Each shipment is delivered under strict cold chain protocols, ensuring the vaccine's integrity and potency upon arrival.
FAQ's of Havrix 720 Junior Monodose Vaccine:
Q: How is Havrix 720 Junior Monodose Vaccine administered?
A: Havrix 720 Junior Monodose Vaccine should be administered intramuscularly as a single 0.5 ml dose, followed by a booster dose 6-12 months after the first injection.
Q: What is the benefit of using Havrix 720 Junior for children?
A: Havrix 720 Junior offers active immunization against hepatitis A, providing reliable and long-lasting protection for children aged 1-15 years with a pre-filled, single-use syringe for convenience.
Q: When is the recommended timing for the booster dose?
A: The booster dose of Havrix 720 Junior should be given 6 to 12 months after the initial dose to ensure sustained immunity against hepatitis A.
Q: Where can I find the batch number for Havrix 720 Junior?
A: The batch number is printed on both the outer carton and the syringe label, ensuring traceability and ease of verification before administration.
Q: What are the main contraindications for Havrix 720 Junior?
A: Havrix 720 Junior should not be administered to individuals with hypersensitivity to any vaccine component or those experiencing an acute febrile illness at the time of intended vaccination.
Q: What should be considered during storage and transportation of the vaccine?
A: The vaccine should be stored between 2C and 8C, kept away from light, and must not be frozen. Packing, transport, and delivery are all managed under these conditions to maintain efficacy.